12
Heteroatom Chemistry
1,6,11(13H)-trione (5c). Figure S7: 13C NMR (62.9 MHz,
DMSO) spectrum of 13-(4-chlorophenyl)-3,3-dimethyl-10-
nitro-2,3,4,13-tetrahydro-1H-indazolo[1,2-b]-phthalazine-
indazolo[2,1-b]phthalazine-triones in neutral ionic liquid 1-
butyl-3-methylimidazolium bromide,” Ultrasonics Sono-
chemistry, vol. 19, no. 2, pp. 307–313, 2012.
[15] M. Sayyafi, M. Seyyedhamzeh, H. R. Khavasi, and A. Bazgir,
“One-pot, three-component route to 2H-indazolo[2,1-b]
phthalazine-triones,” Tetrahedron, vol. 64, no. 10,
pp. 2375–2378, 2008.
References
[16] H. R. Shaterian, M. Ghashang, and M. Feyzi, “Silica sulfuric
acid as an efficient catalyst for the preparation of 2H-indazolo
[2,1-b]phthalazine-triones,” Applied Catalysis A: General,
vol. 345, no. 2, pp. 128–133, 2008.
[1] M. Azab, M. Youssef, and E. El-Bordany, “Synthesis and
antibacterial evaluation of novel heterocyclic compounds
containing a sulfonamido moiety,” Molecules, vol. 18, no. 1,
pp. 832–844, 2013.
[17] H. R. Shaterian, A. Hosseinian, and M. Ghashang, “Reusable
silica supported poly phosphoric acid catalyzed three-com-
ponent synthesis of 2H-indazolo[2,1-b]phthalazine- trione
derivatives,” Arkivoc, vol. 2009, no. 2, pp. 59–67, 2009.
[18] J. M. Khurana and D. Magoo, “Efficient one-pot syntheses of
2H-indazolo[2,1-b]phthalazine-triones by catalytic H2SO4 in
water–ethanol or ionic liquid,” Tetrahedron Letters, vol. 50,
no. 52, pp. 7300–7303, 2009.
[19] E. Mosaddegh and A. Hassankhani, “A rapid, one-pot, four-
component route to 2H-indazolo[2,1-b]phthalazine-triones,”
Tetrahedron Letters, vol. 52, no. 4, pp. 488–490, 2011.
[20] H. R. Shaterian and F. Rigi, “Starch sulfate as an efficient and
biodegradable polymer catalyst for one-pot, four-component
reaction of 2H-indazolo[2,1-b]phthalazine-triones,” Starch-
Sta¨rke, vol. 63, no. 6, pp. 340–346, 2011.
[2] P. Martins, J. Jesus, S. Santos et al., “Heterocyclic anticancer
compounds: recent advances and the paradigm shift towards
the use of nanomedicine’s tool box,” Molecules, vol. 20, no. 9,
pp. 16852–16891, 2015.
[3] F. W. Lichtenthaler, “Unsaturated O- and N-heterocycles
from carbohydrate feedstocks,” Accounts of Chemical Re-
search, vol. 35, no. 9, pp. 728–737, 2002.
[4] S. Grasso, G. De Sarro, A. De Sarro et al., “Synthesis and
anticonvulsant activity of novel and potent 6,7-methyl-
enedioxyphthalazin-1(2H)-ones,” Journal of Medicinal
Chemistry, vol. 43, no. 15, pp. 2851–2859, 2000.
[5] N. Watanabe, Y. Kabasawa, Y. Takase et al., “4-Benzylamino-
1-chloro-6-substituted phthalazines: synthesis and inhibitory
activity toward phosphodiesterase 5,” Journal of Medicinal
Chemistry, vol. 41, no. 18, pp. 3367–3372, 1998.
[6] Y. Nomoto, H. Obase, H. Takai, M. Teranishi, J. Nakamura,
and K. Kubo, “Studies on cardiotonic agents. II. Synthesis of
novel phthalazine and 1,2,3-benzotriazine derivatives,”
[21] A. Ramazani, Y. Ahmadi, M. Rouhani, N. Shajari, and
A. Souldozi, “/e reaction of (N-isocyanimino) triphenyl-
phosphorane with an electron-poor α-haloketone in the
presence of aromatic carboxylic acids: a novel three-com-
ponent reaction for the synthesis of disubstituted 1,3,4-oxa-
diazole derivatives,” Heteroatom Chemistry, vol. 21, no. 6,
pp. 368–372, 2010.
[22] A. Ramazani, N. Shajari, A. Mahyari, and Y. Ahmadi, “A novel
four-component reaction for the synthesis of disubstituted
1,3,4-oxadiazole derivatives,” Molecular Diversity, vol. 15,
no. 2, pp. 521–527, 2011.
[23] N. Shajari, R. Kazemizadeh, and A. Ramazani, “Efficient one-
pot, four-component synthesis of N,N-dibenzyl-N-{1-[5-(3-
aryl)-1,3,4-oxadiazol-2-yl]cyclobutyl}amine derivatives from
the reaction of (isocyanoimino)triphenylphosphorane,
dibenzylamine, an aromatic carboxylic acid and cyclo-
butanone,” Journal of the Serbian Chemical Society, vol. 77,
no. 9, pp. 1175–1180, 2012.
[24] N. Shajari, R. Ghiasi, and A. Ramazani, “One-pot synthesis of
2-acylaminobenzimidazoles from the reaction between tri-
chloroacetyl isocyanate and 1,2-phenylenediamine derivatives
and theoretical study of structure and properties of synthe-
sized 2-acylaminobenzimidazoles,” Journal of the Chilean
Chemical Society, vol. 63, no. 2, pp. 3968–3973, 2018.
[25] R. B. Nazarski, “Physical imageversusstructure relation. Part
14-an attempt to rationalize some acidic region 13C NMR-pH
titration shifts for tetraaza macrocycles throughout the
conformational GIAO DFTcomputational results: a pendant-
armcyclamcase,” Journal of Physical Organic Chemistry,
vol. 22, no. 9, pp. 834–844, 2009.
Chemical
& Pharmaceutical Bulletin, vol. 38, no. 8,
pp. 2179–2183, 1990.
[7] J. S. Kim, H.-K. Rhee, H. J. Park, S. K. Lee, C.-O. Lee, and
H.-Y. Park Choo, “Synthesis of 1-2-substituted-[1,2,3]triazolo
[4,5-g]phthalazine-4,9-diones and evaluation of their cyto-
toxicity and topoisomerase II inhibition,” Bioorganic & Me-
dicinal Chemistry, vol. 16, no. 8, pp. 4545–4550, 2008.
[8] S. El-Shakka, A. Soliman, and A. Imam, “Synthesis, antimi-
crobial activity and electron impact of mass spectra of
phthalazine-1,4-dione derivatives,” Afinidad, vol. 66, no. 544,
pp. 167–172, 2009.
[9] L. Zhang, L.-P. Guan, X.-Y. Sun, C.-X. Wei, K.-Y. Chai, and
Z.-S. Quan, “Synthesis and anticonvulsant activity of 6-
Alkoxy-[1,2,4]Triazolo[3,4-a]Phthalazines,” Chemical Biology
& Drug Design, vol. 73, no. 3, pp. 313–319, 2009.
[10] C.-K. Ryu, R.-E. Park, M.-Y. Ma, and J.-H. Nho, “Synthesis
and antifungal activity of 6-arylamino-phthalazine-5,8-diones
and 6,7-bis(arylthio)-phthalazine-5,8-diones,” Bioorganic &
Medicinal Chemistry Letters, vol. 17, no. 9, pp. 2577–2580,
2007.
[11] J. Li, Y.-F. Zhao, X.-Y. Yuan, J.-X. Xu, and P. Gong, “Synthesis
and anticancer activities of novel 1,4-disubstituted phthala-
zines,” Molecules, vol. 11, no. 7, pp. 574–582, 2006.
[12] J. Sinkkonen, V. Ovcharenko, K. N. Zelenin et al., “1H and 13
C
NMR study of 1-Hydrazino-2,3-dihydro-1H-pyrazolo[1,2-a]
pyridazine-5,8-diones and -1H-pyrazolo[1,2-b]phthalazine-
5,10-diones and their ring-chain tautomerism,” European
Journal of Organic Chemistry, vol. 13, pp. 2046–2053, 2002.
[13] H. R. Shaterian, F. Khorami, A. Amirzadeh,
R. Doostmohammadi, and M. Ghashang, “Preparation of
heterocyclic containing phthalazine skeleton: 2H Indazolo [2,
1-b] phthalazine-1, 6, 11 (13H)-triones,” Journal of the Iranian
Chemical Research, vol. 2, no. 1, pp. 57–62, 2009.
[26] S. Dixit, M. Patil, and N. Agarwal, “Ferrocene catalysed
heteroarylation of BODIPy and reaction mechanism studies
by EPR and DFT methods,” RSC Advances, vol. 6, no. 53,
pp. 47491–47497, 2016.
[27] L. Zheng, Y. Qiao, M. Lu, and J. Chang, “/eoretical inves-
tigations of the reaction between 1,4-dithiane-2,5-diol and
azomethine imines: mechanisms and diastereoselectivity,”
[14] M. Shekouhy and A. Hasaninejad, “Ultrasound-promoted
catalyst-free one-pot four component synthesis of 2H-